Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Tien Liang Biotech Co., Ltd. (4127) Financial Statements

Tien Liang Biotech Co., Ltd. Financial Overview

Tien Liang Biotech Co., Ltd.'s market cap is currently NT$1.65B. The company's EPS TTM is NT$1.51; its P/E ratio is 23.91; and it has a dividend yield of 1.47%. Tien Liang Biotech Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 511.79MNT$ 385.21MNT$ 459.99MNT$ 528.52MNT$ 571.32M
Gross ProfitNT$ 277.86MNT$ 229.91MNT$ 286.15MNT$ 336.55MNT$ 338.28M
Operating IncomeNT$ -16.14MNT$ 593.00KNT$ 20.44MNT$ 61.10MNT$ 50.63M
EBITDANT$ -6.07MNT$ 25.49MNT$ 31.05MNT$ 72.15MNT$ 63.06M
Net IncomeNT$ -10.25MNT$ 11.70MNT$ 17.73MNT$ 59.48MNT$ 46.60M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 152.31MNT$ 130.67MNT$ 142.22MNT$ 107.84MNT$ 118.47M
Total AssetsNT$ 1.18BNT$ 888.68MNT$ 654.03MNT$ 676.43MNT$ 655.35M
Total DebtNT$ 598.54MNT$ 345.20MNT$ 84.66MNT$ 114.13MNT$ 156.87M
Net DebtNT$ 476.23MNT$ 214.53MNT$ -57.56MNT$ 6.29MNT$ 38.40M
Total LiabilitiesNT$ 709.19MNT$ 410.76MNT$ 161.05MNT$ 201.30MNT$ 241.30M
Stockholders' EquityNT$ 474.04MNT$ 477.92MNT$ 492.98MNT$ 475.13MNT$ 414.05M
Cash Flow
Free Cash FlowNT$ 14.33MNT$ 44.20MNT$ 64.33MNT$ 20.87MNT$ 44.61M
Operating Cash FlowNT$ 37.52MNT$ 48.34MNT$ 69.67MNT$ 21.88MNT$ 45.21M
Investing Cash FlowNT$ -299.22MNT$ -301.51MNT$ -4.78MNT$ -1.21MNT$ -1.18M
Financing Cash FlowNT$ 253.34MNT$ 241.62MNT$ -30.52MNT$ -31.30MNT$ -40.80M

Currency in TWD

Tien Liang Biotech Co., Ltd. Earnings and Revenue History

-400M0400M800M-15 %0 %15 %30 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Tien Liang Biotech Co., Ltd. Liabilities to Assets

0500M1B1.5B20 %40 %60 %80 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Tien Liang Biotech Co., Ltd. Cash Flow

-400M-300M-200M-100M0100M200M300M2019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Tien Liang Biotech Co., Ltd. Forecast EPS vs Actual EPS

-1.5-1-0.500.51Q4 24Q1 25Q2 25Q3 25Q3 26EPS EstimateBeatMiss
Earnings >